Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | CHAT | P28329 | 6/20 | 0.51 |
| ▸ | RXRA | P19793 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.49 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.46 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6422555 | 0.89 | HPRT1 (0.52) | ALDH1A1CYP3A4HPGDTSHRKEAP1 | |
| SCHEMBL10706687 | 0.87 | CHAT (0.62) | ALDH1A1TSHRHSD17B10CHATRXRA | |
| SCHEMBL10706700 | 0.87 | CHAT (0.62) | ALDH1A1TSHRHSD17B10CHATRXRA | |
| SCHEMBL10706694 | 0.87 | CHAT (0.62) | ALDH1A1TSHRHSD17B10CHATRXRA | |
| SCHEMBL10437274 | 0.84 | CHAT (0.60) | CHATRXRAPTGS1PTGS2HDAC8 | |
| SCHEMBL10437275 | 0.84 | CHAT (0.60) | CHATRXRAPTGS1PTGS2HDAC8 | |
| SCHEMBL5699729 | 0.82 | ALDH1A1 (0.42) | ALDH1A1CYP3A4HPGDTSHRKEAP1 | |
| SCHEMBL38340 | 0.82 | CYP3A4 (0.53) | ALDH1A1CYP3A4HPGDTSHRKEAP1 | |
| SCHEMBL65321 | 0.82 | CYP3A4 (0.53) | ALDH1A1CYP3A4HPGDTSHRKEAP1 | |
| SCHEMBL3765477 | 0.82 | CYP3A4 (0.53) | ALDH1A1CYP3A4HPGDTSHRKEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7524991-B2 | Organic electroluminescent devices, aminostyrylnaphthalene compounds and synthesis intermediates thereof, and production processes of the same | SONY CORPORATION (JP) | 2009-04-28 | — | — | US | disclosed |
| US-7402344-B2 | Organic electroluminescent devices and aminostyrylnaphthalene compounds | SONY CORPORATION (JP) | 2008-07-22 | — | — | US | disclosed |
| US-20080051607-A1 | ORGANIC ELECTROLUMINESCENT DEVICES, AMINOSTYRLNAPHTHALENE COMPOUNDS AND SYNTHESIS INTERMEDIATES THEREOF, AND PRODUCTION PROCESSES OF THE SAME | SONY CORPORATION (JP) | 2008-02-28 | — | — | US | disclosed |
| US-20040265627-A1 | Organic electroluminescent devices, aminostyrylnaphthalene compound and synthesis intermediates thereof, and production processes of the same | JDI DESIGN AND DEVELOPMENT G.K. (JP) | 2004-12-30 | — | — | US | disclosed |
| EP-1473349-A2 | Organic electroluminescent devices, aminostyrylnaphthalene compounds and synthesis intermediates thereof, and production processes of the same | SONY CORPORATION (JP) | 2004-11-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080051607-A1 | ORGANIC ELECTROLUMINESCENT DEVICES, AMINOSTYRLNAPHTHALENE COMPOUNDS AND SYNTHESIS INTERMEDIATES THEREOF, AND PRODUCTION PROCESSES OF THE SAME | ASNS, RPS24, L1CAM | ALDH1A1 798/4885CYP3A4 314/4885HPGD 2443/4885 |
| US-20040265627-A1 | Organic electroluminescent devices, aminostyrylnaphthalene compound and synthesis intermediates thereof, and production processes of the same | RPS24, RPL24, CHRND | ALDH1A1 328/4885CYP3A4 611/4885HPGD 2434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.